Clofoctol

DB13237ExperimentalSmall molecule

Clofoctol is an antibacterial agent indicated in the treatment of respiratory infections; or prevention of infections after ear, nose, and throat surgery.

Mechanism: Pharmacologically active on Cell division cycle 7-related protein kinase and Cold shock domain-containing protein E1
Curator reviewed
Formula / weight: C₂₁H₂₆Cl₂O · 365.34 g/mol (avg)
Also known as: Octofene
Code names: BRN 2478182

Resolves to

Compound

UNII704083NI0RCAS37693-01-9ChEMBLCHEMBL1476605ChEBI108581

Clinical / RWD

RxNorm21264ATCJ01XX03

Structure

InChIKeyHQVZOORKDNCGCK-UHFFFAOYSA-NSMILESCC(C)(C)CC(C)(C)C1=CC=C(O)C(CC2=C(Cl)C=C(Cl)C=C2)=C1

Targets

O00311CDC7O75534CSDE1

What you can answer from here — as of July 07, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

3Structured indicationsCondition, population, route and combination as fields, not prose

2ContraindicationsEach with its own population and attribute set

5Marketed productsAcross 1 country and 1 labeller

1ATC codeIncluding every combination product, plus 6 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Clofoctol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Log In Paid Account Log In